Skip to main content

Articles

Practice Management
Estimating the Costs of Therapy in Patients with Relapsed and/or Refractory Multiple Myeloma: A Model Framework
Stakeholder Perspective
The Rationale for Comparing the Costs of Competing Treatment Options in Oncology
Read More
Practice Management
Oncology Innovation and Challenging Choices: Balancing Value and Funding Priorities in Light of an Abundance of New Treatment Options
Read More
FDA Approvals
The 2015 Oncology Drug Pipeline: Innovation Drives the Race to Cure Cancer
Read More
Perspectives
Did the “HEN” Lay a Rotten Egg?
Read More
Practice Management
Breaking the Bank: Three Financing Models for Addressing the Drug Innovation Cost Crisis
Stakeholder Perspective
Financing Drug Innovation: Cost versus Cure
Read More
Practice Management
Demonstrating Value for Biosimilars: A Conceptual Framework
Stakeholder Perspective
Challenges Surrounding the New Biosimilars Landscape
Read More
Practice Management
Adherence to Insulin Pen Therapy Is Associated with Reduction in Healthcare Costs Among Patients with Type 2 Diabetes Mellitus
Stakeholder Perspective
Adherence to Antihyperglycemic Treatment Regimen Also Reduces Overall Costs
Read More
Conference Highlights AMCP
Payers’ Perspectives: Health Economics Outcomes in Managed Care
Read More
Perspectives
A Silver Anniversary of the Internet
Read More
Original Research
Cardiovascular-Related Healthcare Resource Utilization and Costs in Patients with Hypertension Switching from Metoprolol to Nebivolol
Stakeholder Perspective
Moving Beyond Measures into Outcomes in Hypertension Research
Read More
Page 132 of 244
Results 1311 - 1320 of 2436